SEC 13F Intelligence

Alerce Investment Management, L.P. / RNTX

Alerce Investment Management, L.P.’s Rein Therapeutics Inc Position

Does Alerce Investment Management, L.P. own Rein Therapeutics Inc (RNTX)? Not currently — the last reported position was 830.5K shares worth $6M in Q1 2024; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$6M
Q1 2024
Shares
830.5K
% of Portfolio
+5.79%
Quarters Held
6
position exited

Position History RNTX

Reported value by quarter
Q4 ’22: $2MQ4 ’22Q1 ’23: $1MQ1 ’23Q2 ’23: $1MQ2 ’23Q3 ’23: $1MQ3 ’23Q4 ’23: $3MQ4 ’23Q1 ’24: $6MQ1 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2024830.5K$6M+5.79%
Q4 2023830.5K$3M+3.37%
Q3 2023830.5K$1M+2.16%
Q2 2023830.5K$1M+1.93%
Q1 2023830.5K$1M+1.36%
Q4 2022830.5K$2M+2.26%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Alerce Investment Management, L.P.’s full portfolio or all institutional holders of RNTX.